Souders Financial Advisors Sells 512 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Souders Financial Advisors reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,724 shares of the medical equipment provider’s stock after selling 512 shares during the period. Souders Financial Advisors’ holdings in Intuitive Surgical were worth $1,422,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the fourth quarter worth $28,000. Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $31,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at $36,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Truist Financial upped their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Stifel Nicolaus upped their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG opened at $557.96 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $198.73 billion, a P/E ratio of 87.05, a P/E/G ratio of 5.85 and a beta of 1.39. The firm’s 50 day simple moving average is $571.08 and its 200 day simple moving average is $530.63.

Insider Activity

In related news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 12,598 shares of company stock worth $7,223,467. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.